Showing results 1 to 20 of 25
next >
| Issue Date | Title | Author(s) |
| 2014-01-01 | Across the pulmonary epithelial barrier: Integration of physicochemical properties and human cell models to study pulmonary drug formulations | Haghi, M; Ong, HX; Traini, D; Young, P |
| 2020-11 | An in vitro model for assessing drug transport in cystic fibrosis treatment: Characterisation of the CuFi-1 cell line. | Sheikh, Z; Bradbury, P; Pozzoli, M; Young, PM; Ong, HX; Traini, D |
| 2022-04-02 | Application of Micro-Engineered Kidney, Liver, and Respiratory System Models to Accelerate Preclinical Drug Testing and Development. | Gholizadeh, H; Cheng, S; Kourmatzis, A; Xing, H; Traini, D; Young, PM; Ong, HX |
| 2016-10-01 | Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products | Pozzoli, M; Ong, HX; Morgan, L; Sukkar, M; Traini, D; Young, PM; Sonvico, F |
| 2011-01 | Cellular release profiling of controlled release dry powder pulmonary formulation | Ong, HX; Traini, D; Bebawy, M; Young, P; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Young, PM |
| 2023-11 | Challenges and current advances in in vitro biofilm characterization. | Zhang, Y; Young, P; Traini, D; Li, M; Ong, HX; Cheng, S |
| 2013-06-01 | Ciprofloxacin is actively transported across bronchial lung epithelial cells using a calu-3 air interface cell model | Ong, HX; Traini, D; Bebawy, M; Young, PM |
| 2021-03-01 | Development and in vitro characterization of a novel pMDI diclofenac formulation as an inhalable anti-inflammatory therapy for cystic fibrosis. | Sheikh, Z; Gomes Dos Reis, L; Bradbury, P; Meneguzzo, G; Scalia, S; Young, PM; Ong, HX; Traini, D |
| 2011-09-01 | Epithelial profiling of antibiotic controlled release respiratory formulations | Ong, HX; Traini, D; Bebawy, M; Young, PM |
| 2021-08-05 | How Do Mechanics Guide Fibroblast Activity? Complex Disruptions during Emphysema Shape Cellular Responses and Limit Research. | Leslie, MN; Chou, J; Young, PM; Traini, D; Bradbury, P; Ong, HX |
| 2014-01-01 | In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation | Ong, HX; Benaouda, F; Traini, D; Cipolla, D; Gonda, I; Bebawy, M; Forbes, B; Young, PM |
| 2012-01 | Inhaled Liposomal Ciprofloxacin Nanoparticles Control the Release of Antibiotic at the Bronchial Epithelia | Ong, HX; Cipolla, DC; Gonda, I; Traini, D; Bebawy, M; Agus, H; Young, PM; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Farr, SJ; Young, PM |
| 2012-12-01 | Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia | Ong, HX; Traini, D; Cipolla, D; Gonda, I; Bebawy, M; Agus, H; Young, PM |
| 2020-01 | Modifying and Integrating <i>in vitro</i> and <i>ex vivo</i> Respiratory Models for Inhalation Drug Screening. | Cidem, A; Bradbury, P; Traini, D; Ong, HX |
| 2013-08-01 | Multiple dosing of simvastatin inhibits airway mucus production of epithelial cells: Implications in the treatment of chronic obstructive airway pathologies | Marin, L; Traini, D; Bebawy, M; Colombo, P; Buttini, F; Haghi, M; Ong, HX; Young, P |
| 2022-02-22 | Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract. | Zhang, Y; Almazi, JG; Ong, HX; Johansen, MD; Ledger, S; Traini, D; Hansbro, PM; Kelleher, AD; Ahlenstiel, CL |
| 2014-01 | Optimization of RPMI 2650 Cells as a Model for Nasal Mucosa | Pozzoli, M; Sonvico, F; Ong, HX; Traini, D; Bebawy, M; Young, P; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Farr, SJ; Young, PM; Traini, D |
| 2020-08-21 | Properties of rapamycin solid lipid nanoparticles for lymphatic access through the lungs & part I: the effect of size. | Landh, E; M Moir, L; Bradbury, P; Traini, D; M Young, P; Ong, HX |
| 2023-03 | Real-time in-situ electrochemical monitoring of Pseudomonas aeruginosa biofilms grown on air-liquid interface and its antibiotic susceptibility using a novel dual-chamber microfluidic device. | Zhang, Y; Gholizadeh, H; Young, P; Traini, D; Li, M; Ong, HX; Cheng, S |
| 2021-06 | Real-time quantitative monitoring of in vitro nasal drug delivery by a nasal epithelial mucosa-on-a-chip model. | Gholizadeh, H; Ong, HX; Bradbury, P; Kourmatzis, A; Traini, D; Young, P; Li, M; Cheng, S |
